nach oben

Erschienen in:

01.04.2022 | Glaukom | CME

Sekundäre Offenwinkelglaukome: Pseudoexfoliationsglaukom, Pigmentglaukom und Neovaskularisationsglaukom

verfasst von: Dr. Roman Greslechner, Prof. Dr. Horst Helbig, Prof. Dr. Detlev Spiegel

Erschienen in: Die Ophthalmologie | Ausgabe 4/2022

zum CME-Kurs Einloggen, um Zugang zu erhalten

Zusammenfassung

Die sekundären Offenwinkelglaukome sind eine heterogene Gruppe von Erkrankungen, bei denen unterschiedliche Pathomechanismen zu einem Anstieg des Augendrucks führen. Dieser Beitrag stellt den ersten Teil einer Übersicht über die häufigsten Formen dar. Die Pathogenese, das typische klinische Erscheinungsbild und die Therapie der Pseudoexfoliations‑, Pigment- und Neovaskularisationsglaukome werden diskutiert. Insbesondere werden Unterschiede in der Behandlung gegenüber den primären Offenwinkelglaukomen herausgearbeitet und – wo möglich – prophylaktische Therapieansätze erörtert.

EGS (2021) European glaucoma society terminology and guidelines for glaucoma, 5th edition. Br J Ophthalmol 105:1–169. https://doi.org/10.1136/bjophthalmol-2021-egsguidelines CrossRef

Schlötzer-Schrehardt U, Zenkel M (2019) The role of lysyl oxidase-like 1 (LOXL1) in exfoliation syndrome and glaucoma. Exp Eye Res 189:107818. https://doi.org/10.1016/j.exer.2019.107818 CrossRefPubMed

Ringvold A, Blika S, Sandvik L (1997) Pseudoexfoliation and mortality. Acta Ophthalmol Scand 75:255–256. https://doi.org/10.1111/j.1600-0420.1997.tb00767.x CrossRefPubMed

Shrum KR, Hattenhauer MG, Hodge D (2000) Cardiovascular and cerebrovascular mortality associated with ocular pseudoexfoliation. Am J Ophthalmol 129:83–86. https://doi.org/10.1016/s0002-9394(99)00255-x CrossRefPubMed

Mitchell P, Wang JJ, Smith W (1997) Association of pseudoexfoliation syndrome with increased vascular risk. Am J Ophthalmol 124:685–687. https://doi.org/10.1016/s0002-9394(14)70908-0 CrossRefPubMed

Karger RA, Jeng SM, Johnson DH et al (2003) Estimated incidence of pseudoexfoliation syndrome and pseudoexfoliation glaucoma in Olmsted County, Minnesota. J Glaucoma 12:193–197. https://doi.org/10.1097/00061198-200306000-00002 CrossRefPubMed

Puska PM (2002) Unilateral exfoliation syndrome: conversion to bilateral exfoliation and to glaucoma: a prospective 10-year follow-up study. J Glaucoma 11:517–524. https://doi.org/10.1097/00061198-200212000-00012 CrossRefPubMed

Ekström C (1993) Elevated intraocular pressure and pseudoexfoliation of the lens capsule as risk factors for chronic open-angle glaucoma. Acta Ophthalmol 71:189–195. https://doi.org/10.1111/j.1755-3768.1993.tb04989.x CrossRef

Mitchell P, Wang JJ, Hourihan F (1999) The relationship between glaucoma and pseudoexfoliation: the blue mountains eye study. Arch Ophthalmol 117:1319–1324. https://doi.org/10.1001/archopht.117.10.1319 CrossRefPubMed

10.

Topouzis F, Harris A, Wilson MR et al (2009) Increased likelihood of glaucoma at the same screening intraocular pressure in subjects with pseudoexfoliation: the Thessaloniki eye study. Am J Ophthalmol 148:606–613.e1. https://doi.org/10.1016/j.ajo.2009.03.024 CrossRefPubMed

11.

Ritch R, Schlötzer-Schrehardt U (2001) Exfoliation syndrome. Surv Ophthalmol 45:265–315. https://doi.org/10.1016/s0039-6257(00)00196-x CrossRefPubMed

12.

Helbig H, Schlötzer-Schrehardt U, Noske W et al (1994) Anterior-chamber hypoxia and iris vasculopathy in pseudoexfoliation syndrome. Ger J Ophthalmol 3:148–153 PubMed

13.

Konstas AGP, Holló G, Irkec M et al (2007) Diurnal IOP control with bimatoprost versus latanoprost in exfoliative glaucoma: a crossover, observer-masked, three-centre study. Br J Ophthalmol 91:757. https://doi.org/10.1136/bjo.2006.106690 CrossRefPubMed

14.

Sandhu S, Damji KF (2018) Laser management of glaucoma in exfoliation syndrome. J Glaucoma 27:S91–S94. https://doi.org/10.1097/ijg.0000000000000909 CrossRefPubMed

15.

Holló G, Katsanos A, Konstas A‑G (2015) Management of exfoliative glaucoma: challenges and solutions. Clin Ophthalmol 9:907–919. https://doi.org/10.2147/opth.s77570 CrossRefPubMedPubMedCentral

16.

Serguhn S, Spiegel D (1999) Vergleich des postoperativen Verlaufes nach Trabekulektomie bei Pseudoexfoliationsglaukom und primärem chronischen Offenwinkelglaukom. Klin Monbl Augenheilkd 215:281–286. https://doi.org/10.1055/s-2008-1034715 CrossRefPubMed

17.

Gillies WE, Brooks AM (2002) Central retinal vein occlusion in pseudoexfoliation of the lens capsule. Clin Exp Ophthalmol 30:176–187. https://doi.org/10.1046/j.1442-9071.2002.00513.x CrossRefPubMed

18.

Tojo N, Hayashi A (2021) Ex-Press® versus Baerveldt implant surgery for primary open-angle glaucoma and pseudo-exfoliation glaucoma. Int Ophthalmol 41:1091–1101. https://doi.org/10.1007/s10792-020-01668-y CrossRefPubMed

19.

Ollikainen ML, Puustjärvi TJ, Rekonen PK et al (2011) Mitomycin C‑augmented deep sclerectomy in primary open-angle glaucoma and exfoliation glaucoma: a three-year prospective study. Acta Ophthalmol 89:548–555. https://doi.org/10.1111/j.1755-3768.2009.01772.x CrossRefPubMed

20.

Seuthe A‑M, Ivanescu C, Leers S et al (2016) Modified canaloplasty with suprachoroidal drainage versus conventional canaloplasty—1-year results. Graefes Arch Clin Exp Ophthalmol 254:1591–1597. https://doi.org/10.1007/s00417-016-3370-6 CrossRefPubMed

21.

Seuthe A‑M, Szurman P, Januschowski K (2020) Canaloplasty with suprachoroidal drainage in patients with pseudoexfoliation glaucoma—four years results. Curr Eye Res 46:1–7. https://doi.org/10.1080/02713683.2020.1795203 CrossRef

22.

Puska P, Tarkkanen A (2001) Exfoliation syndrome as a risk factor for cataract development five-year follow-up of lens opacities in exfoliation syndrome. J Cataract Refract Surg 27:1992–1998. https://doi.org/10.1016/s0886-3350(01)00972-5 CrossRefPubMed

23.

Ruotsalainen J, Tarkkanen A (1987) Capsule thickness of cataractous lenses with and without exfoliation syndrome. Acta Ophthalmol 65:444–449. https://doi.org/10.1111/j.1755-3768.1987.tb07021.x CrossRef

24.

Jehan FS, Mamalis N, Crandall AS (2001) Spontaneous late dislocation of intraocular lens within the capsular bag in pseudoexfoliation patients. Ophthalmology 108:1727–1731. https://doi.org/10.1016/s0161-6420(01)00710-2 CrossRefPubMed

25.

Damji KF, Konstas AGP, Liebmann JM et al (2006) Intraocular pressure following phacoemulsification in patients with and without exfoliation syndrome: a 2 year prospective study. Br J Ophthalmol 90:1014. https://doi.org/10.1136/bjo.2006.091447 CrossRefPubMedPubMedCentral

26.

Kristianslund O, Østern AE, Råen M et al (2016) Does cataract surgery reduce the long-term risk of glaucoma in eyes with pseudoexfoliation syndrome? Acta Ophthalmol 94:261–265. https://doi.org/10.1111/aos.12945 CrossRefPubMed

27.

Jacobi PC, Dietlein TS, Krieglstein GK (1998) Bimanual trabecular aspiration in pseudoexfoliation glaucoma an alternative in nonfiltering glaucoma surgery. Ophthalmology 105:886–894. https://doi.org/10.1016/s0161-6420(98)95032-1 CrossRefPubMed

28.

Ferguson TJ, Swan RJ, Bleeker A et al (2020) Trabecular microbypass stent implantation in pseudoexfoliative glaucoma: long-term results. J Cataract Refract Surg 46:1284–1289. https://doi.org/10.1097/j.jcrs.0000000000000243 CrossRefPubMed

29.

Pahlitzsch M, Gonnermann J, Maier A‑K et al (2015) Trabekulotomie ab interno (Trabectome) – Kumulierte klinische Ergebnisse eines großen Glaukomkollektivs. Klin Monbl Augenheilkd 232:1198–1207. https://doi.org/10.1055/s-0041-105941 CrossRefPubMed

30.

Iwasaki K, Takamura Y, Orii Y et al (2020) Performances of glaucoma operations with Kahook dual blade or iStent combined with phacoemulsification in Japanese open angle glaucoma patients. Int J Ophthalmol 13:941–945. https://doi.org/10.18240/ijo.2020.06.13 CrossRefPubMedPubMedCentral

31.

Siddiqui Y, Hulzen RDT, Cameron JD et al (2003) What is the risk of developing pigmentary glaucoma from pigment dispersion syndrome? Am J Ophthalmol 135:794–799. https://doi.org/10.1016/s0002-9394(02)02289-4 CrossRefPubMed

32.

Scuderi G, Contestabile MT, Scuderi L et al (2019) Pigment dispersion syndrome and pigmentary glaucoma: a review and update. Int Ophthalmol 39:1651–1662. https://doi.org/10.1007/s10792-018-0938-7 CrossRefPubMed

33.

Niyadurupola N, Broadway DC (2008) Pigment dispersion syndrome and pigmentary glaucoma—a major review. Clin Exp Ophthalmol 36:868–882. https://doi.org/10.1111/j.1442-9071.2009.01920.x CrossRefPubMed

34.

Karickhoff JR (1992) Pigmentary dispersion syndrome and pigmentary glaucoma: a new mechanism concept, a new treatment, and a new technique. Ophthalmic Surg Lasers Imaging Retina 23:269–277. https://doi.org/10.3928/1542-8877-19920401-11 CrossRef

35.

Breingan PJ, Esaki K, Ishikawa H et al (1999) Iridolenticular contact decreases following laser iridotomy for pigment dispersion syndrome. Arch Ophthalmol 117:325–328. https://doi.org/10.1001/archopht.117.3.325 CrossRefPubMed

36.

Gupta N, Weinreb RN (1997) New definitions of glaucoma. Curr Opin Ophthalmol 8:38–41. https://doi.org/10.1097/00055735-199704000-00007 CrossRefPubMed

37.

Lichter PR, Shaffer RN (1970) Diagnostic and prognostic signs in pigmentary glaucoma. Trans Am Acad Ophthalmol Otolaryngol 74:984–998 PubMed

38.

Ritch R, Liebmann J, Robin A et al (1993) Argon laser trabeculoplasty in pigmentary glaucoma. Ophthalmology 100:909–913. https://doi.org/10.1016/s0161-6420(93)31555-1 CrossRefPubMed

39.

Ayala M (2014) Long-term outcomes of selective laser trabeculoplasty (SLT) treatment in pigmentary glaucoma patients. J Glaucoma 23:616–619. https://doi.org/10.1097/ijg.0b013e318287abb7 CrossRefPubMed

40.

Harasymowycz PJ, Papamatheakis DG, Latina M et al (2005) Selective laser trabeculoplasty (SLT) complicated by intraocular pressure elevation in eyes with heavily pigmented trabecular meshworks. Am J Ophthalmol 139:1110–1113. https://doi.org/10.1016/j.ajo.2004.11.038 CrossRefPubMed

41.

Okafor K, Vinod K, Gedde SJ (2017) Update on pigment dispersion syndrome and pigmentary glaucoma. Curr Opin Ophthalmol 28:154–160. https://doi.org/10.1097/icu.0000000000000352 CrossRefPubMed

42.

Setlur VJ, Parikh JG, Rao NA (2010) Changing causes of enucleation over the past 60 years. Graefes Arch Clin Exp Ophthalmol 248:593–597. https://doi.org/10.1007/s00417-009-1262-8 CrossRefPubMed

43.

Havens SJ, Gulati V (2015) Neovascular glaucoma. Dev Ophthalmol 55:196–204. https://doi.org/10.1159/000431196 CrossRefPubMedPubMedCentral

44.

Lin P‑A, Lee C‑Y, Huang F‑C et al (2020) Trend of neovascular nlaucoma in Taiwan: a 15-year nationwide population-based cohort study. Ophthalmic Epidemiol 27:1–9. https://doi.org/10.1080/09286586.2020.1755445 CrossRef

45.

Browning DJ, Scott AQ, Peterson CB et al (1998) The risk of missing angle neovascularization by omitting screening gonioscopy in acute central retinal vein occlusion. Ophthalmology 105:776–784. https://doi.org/10.1016/s0161-6420(98)95014-x CrossRefPubMed

46.

Blinder KJ, Friedman SM, Mames RN (1995) Diabetic iris neovascularization. Am J Ophthalmol 120:393–395. https://doi.org/10.1016/s0002-9394(14)72173-7 CrossRefPubMed

47.

No authors listed (1993) Baseline and early natural history report: the central vein occlusion study. Arch Ophthalmol 111:1087–1095. https://doi.org/10.1001/archopht.1993.01090080083022 CrossRef

48.

Tasman W, Magargal LE, Augsburger JJ (1980) Effects of argon laser photocoagulation on rubeosis iridis and angle neovascularization. Ophthalmology 87:400–402. https://doi.org/10.1016/s0161-6420(80)35225-1 CrossRefPubMed

49.

Armaly MF, Baloglou PJ (1967) Diabetes mellitus and the eye: 1. Changes in the anterior segment. Arch Ophthalmol 77:485–492. https://doi.org/10.1001/archopht.1967.00980020487011 CrossRefPubMed

50.

Madsen PH (1971) Haemorrhagic glaucoma. Comparative study in diabetic and nondiabetic patients. Br J Ophthalmol 55:444–450. https://doi.org/10.1136/bjo.55.7.444 CrossRefPubMedPubMedCentral

51.

Ohrt V (1971) The frequency of rubeosis iridis in diabetic patients. Acta Ophthalmol 49:301–307. https://doi.org/10.1111/j.1755-3768.1971.tb00954.x CrossRef

52.

Nielsen NV (1983) The prevanlence of glaucoma and ocular hypertension in type 1 and 2 diabetes mellitus. An epidemiological study of diabetes mellitus on the island of Falster, Denmark. Acta Ophthalmol 61:662–672. https://doi.org/10.1111/j.1755-3768.1983.tb04357.x CrossRef

53.

Rudkin AK, Lee AW, Chen CS (2010) Ocular neovascularization following central retinal artery occlusion: prevalence and timing of onset. Eur J Ophthalmol 20:1042–1046. https://doi.org/10.1177/112067211002000603 CrossRefPubMed

54.

Neupert JR, Brubaker RF, Kearns TP et al (1976) Rapid resolution of venous stasis retinopathy after carotid endarterectomy. Am J Ophthalmol 81:600–602. https://doi.org/10.1016/0002-9394(76)90123-9 CrossRefPubMed

55.

Ohnishi Y, Ishibashi T, Sagawa T (1994) Fluorescein gonioangiography in diabetic neovascularisation. Graefes Arch Clin Exp Ophthalmol 232:199–204. https://doi.org/10.1007/bf00184005 CrossRefPubMed

56.

Horsley MB, Kahook MY (2010) Anti-VEGF therapy for glaucoma. Curr Opin Ophthalmol 21:112–117. https://doi.org/10.1097/icu.0b013e3283360aad CrossRefPubMed

57.

Wakabayashi T, Oshima Y, Sakaguchi H et al (2008) Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Ophthalmology 115:1571–1580.e3. https://doi.org/10.1016/j.ophtha.2008.02.026 CrossRefPubMed

58.

Yazdani S, Hendi K, Pakravan M et al (2009) Intravitreal bevacizumab for neovascular glaucoma. J Glaucoma 18:632–637. https://doi.org/10.1097/ijg.0b013e3181997211 CrossRefPubMed

59.

Olmos LC, Sayed MS, Moraczewski AL et al (2016) Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab. Eye (Lond) 30:463–472. https://doi.org/10.1038/eye.2015.259 CrossRef

60.

Takihara Y, Inatani M, Fukushima M et al (2009) Trabeculectomy with mitomycin C for neovascular glaucoma: prognostic factors for surgical failure. Am J Ophthalmol 147:912–918.e1. https://doi.org/10.1016/j.ajo.2008.11.015 CrossRefPubMed

61.

Shen CC, Salim S, Du H, Netland PA (2011) Trabeculectomy versus Ahmed glaucoma valve implantation in neovascular glaucoma. Clin Ophthalmol 5:281–286. https://doi.org/10.2147/opth.s16976 CrossRefPubMedPubMedCentral

62.

Ghosh S, Singh D, Ruddle JB et al (2010) Combined diode laser cyclophotocoagulation and intravitreal bevacizumab (Avastin) in neovascular glaucoma. Clin Exp Ophthalmol 38:353–357. https://doi.org/10.1111/j.1442-9071.2010.02285.x CrossRefPubMed

63.

Iliev ME, Gerber S (2007) Long-term outcome of trans-scleral diode laser cyclophotocoagulation in refractory glaucoma. Br J Ophthalmol 91:1631–1635. https://doi.org/10.1136/bjo.2007.116533 CrossRefPubMedPubMedCentral

64.

Murphy CC, Burnett CAM, Spry PGD et al (2003) A two centre study of the dose-response relation for transscleral diode laser cyclophotocoagulation in refractory glaucoma. Br J Ophthalmol 87:1252. https://doi.org/10.1136/bjo.87.10.1252 CrossRefPubMedPubMedCentral

65.

Yildirim N, Yalvac IS, Sahin A et al (2009) A comparative study between diode laser cyclophotocoagulation and the Ahmed glaucoma valve implant in neovascular glaucoma. J Glaucoma 18:192–196. https://doi.org/10.1097/ijg.0b013e31817d235c CrossRefPubMed

66.

Strzalkowski P, Strzalkowska A, Göbel W et al (2020) Combined vitrectomy, near-confluent panretinal endolaser, bevacizumab and cyclophotocoagulation for neovascular glaucoma — a retrospective interventional case series. F1000Res 9:1236. https://doi.org/10.12688/f1000research.26879.2 CrossRefPubMed

Titel: Sekundäre Offenwinkelglaukome: Pseudoexfoliationsglaukom, Pigmentglaukom und Neovaskularisationsglaukom
verfasst von: Dr. Roman Greslechner
Prof. Dr. Horst Helbig
Prof. Dr. Detlev Spiegel
Publikationsdatum: 01.04.2022
Verlag: Springer Medizin
Schlagwörter: Glaukom
Lasertherapie in der Augenheilkunde
Trabekulotomie
Diabetische Retinopathie
Erschienen in: Die Ophthalmologie / Ausgabe 4/2022
Print ISSN: 2731-720X
Elektronische ISSN: 2731-7218
DOI: https://doi.org/10.1007/s00347-022-01609-3

Neu im Fachgebiet Augenheilkunde

25.05.2022 | Praxisrelevante Urteile | CME

Patientenaufklärung vor Augenoperationen

Open Access 23.05.2022 | Originalien

Wissenschaftliche Leistungen augenheilkundlicher Forschungseinrichtungen in Deutschland 2018 bis 2020

Studien, Publikationen, Drittmittelförderungen und mehr – Die Forschungslandkarte der Deutschen Ophthalmologischen Gesellschaft (DOG)

26.04.2022 | Glaukom | CME

Sekundäre Offenwinkelglaukome: uveitische Sekundärglaukome, Steroidglaukom, posttraumatische/postoperative Glaukome, tumorbedingte Glaukome und Glaukome im Rahmen eines erhöhten episkleralen Venendrucks

25.04.2022 | Katarakt | Leitthema

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2022

Gorlin-Goltz-Syndrom – nicht nur ein Syndrom maligner Lidtumoren

Subretinale Lufteingabe zur Behandlung postoperativer Netzhautfalten nach Ablatio

Einstellung von Patienten zu möglicher Telemedizin in der Ophthalmologie

Neue Variante im ADAMTS10-Gen bei 30‑jähriger Patientin mit Myopie und Engwinkelglaukom

CyPass-Mikrostent-Kürzung mittels spezieller Schneidezange

Histologische Veränderungen beim Keratokonus und Wundheilung nach kornealem Crosslinking

Neu im Fachgebiet Augenheilkunde

Patientenaufklärung vor Augenoperationen

Wissenschaftliche Leistungen augenheilkundlicher Forschungseinrichtungen in Deutschland 2018 bis 2020

Sekundäre Offenwinkelglaukome: uveitische Sekundärglaukome, Steroidglaukom, posttraumatische/postoperative Glaukome, tumorbedingte Glaukome und Glaukome im Rahmen eines erhöhten episkleralen Venendrucks

Ressourceneinsatz in der Kataraktchirurgie – Mehr Müll geht (n)immer